RNU7-194P

Across TCGA pan-cancer cohorts, RNU7-194P RNA is linked to patient survival in 6 of 34 cancer types, making it the most broadly survival-associated RNU7-194P data layer.

The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where higher RNU7-194P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU7-194P expression acts as an unfavorable survival marker, although some lineages such as BRCA show a favorable association.

KIRP, BLCA, and HNSC are the cancer types where RNU7-194P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRP	DFS	Tertile	II,III,IV	0.169	0.702	.011	54	view →
BLCA	DFS	Tertile	All	0.159	0.630	<.001	39	view →
HNSC	OS	Tertile	III,IV	0.059	0.674	<.001	36	view →
KICH	DFS	Tertile	III,IV	0.043	0.774	.005	27	view →
STAD	DFS	Quartile	All	0.431	0.593	.003	16	view →
BRCA	DFS	Tertile	IV	1.000	0.638	.042	6	view →

Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

RNU7-194P–KIRP (DFS)

Open the KIRP breakdown →